Evidence map›Paper›PMID 34151162›Full record

ArticleAccess microbiology2021

Sae Okuda, Takeaki Wajima, Tetsuya Yamada, Hidemasa Nakaminami, Hideaki Ikoshi, Norihisa Noguchi

Open access · goldAbstract read
In one paragraph

Article in Access microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Effect of Purslane (International journal of molecular sciences · 2023
    Article
  4. Frontiers in microbiology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Sae OkudaDepartment of Microbiology, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan.
Takeaki WajimaDepartment of Microbiology, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan.ORCID https://orcid.org/0000-0001-9506-707X
Tetsuya YamadaDepartment of Traditional Chinese Medicine, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan.
Hidemasa NakaminamiDepartment of Microbiology, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan.ORCID https://orcid.org/0000-0003-2889-8257
Hideaki IkoshiDepartment of Traditional Chinese Medicine, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan.
Norihisa NoguchiDepartment of Microbiology, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan.ORCID https://orcid.org/0000-0003-4710-7297
Tokyo University of Pharmacy and Life Sciences · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionEmpirical evidence suggests that

aimThe aim of this study is to clarify the growth-inhibitory effects of METHODOLOGY: 'Gogyo-so-cha (GSC)' was used as the

resultsGSC demonstrated strong bactericidal effects against

conclusionGSC significantly inhibited the growth of intestinal pathogens, including

Indexed as

CholeraDysenteryPortulaca oleracea L.Shigella dysenteriaeVibrio cholerae

Identifiers

PMID34151162
PMCPMC8209698
OpenAlexW3131604759

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.